0001019687-15-000991 Sample Contracts

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 16th, 2015 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 13, 2015, by and among Oculus Innovative Sciences, Inc., a Delaware corporation, with its principal place of business at 1129 N. McDowell Blvd., Petaluma, CA 94954 (the “Seller”), the investors listed on Schedule A hereto respective assignee(s) (collectively, the “Buyers”) and, solely with respect to Section 4 and 10 of this Agreement, Ruthigen, Inc., a Delaware corporation (the “Company”) and Dawson James Securities, Inc. (the “Underwriter”).

AutoNDA by SimpleDocs
Contract
Agreement • March 16th, 2015 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • Delaware

This Agreement (the “Agreement”), dated as of March 13, 2015, by and among Oculus Innovative Sciences, Inc., a Delaware corporation, with its principal place of business at 1129 N. McDowell Blvd., Petaluma, CA 94954 (“Oculus”) and Pulmatrix, Inc., a Delaware corporation, with its principal place of business at 99 Hayden Avenue, Suite 390, Lexington, MA 02421 (“Pulmatrix”).

Contract
Agreement • March 16th, 2015 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California

This Agreement (the “Agreement”), dated as of March 13, 2015 (the “Effective Date”), by and among Oculus Innovative Sciences, Inc., a Delaware corporation, with its principal place of business at 1129 N. McDowell Blvd., Petaluma, CA 94954 (“Oculus”), Ruthigen, Inc., a Delaware corporation, with its principal place of business at 2455 Bennett Valley Road, Suite C116, Santa Rosa, CA 95404 (“Ruthigen”) and Hoji Alimi.

SECURITIES PURCHASE Follow-Up AGREEMENT
Securities Purchase Follow-Up Agreement • March 16th, 2015 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California

This SECURITIES PURCHASE FOLLOW-UP AGREEMENT (the “Follow-Up Agreement”), dated as of March 13, 2015, by and among Oculus Innovative Sciences, Inc., a Delaware corporation, with its principal place of business at 1129 N. McDowell Blvd., Petaluma, CA 94954 (the “Seller”), Michael Brauser and Barry Honig or their respective assignee(s) (collectively, the “Buyer”), Ruthigen, Inc., a Delaware corporation (the “Company”) and Dawson James Securities, Inc. (the “Underwriter”).

Time is Money Join Law Insider Premium to draft better contracts faster.